Evidence map›Paper›PMID 34262013›Full record

ArticleSignal transduction and targeted therapy2021

Real-world evidence for improved outcomes with histamine antagonists and aspirin in 22,560 COVID-19 patients.

Cameron Mura, Saskia Preissner, Susanne Nahles, Max Heiland, Philip E Bourne, Robert Preissner

Abstract readLetterComment
In one paragraph

Article in Signal transduction and targeted therapy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Models for COVID-19 Early Cardiac Pathology Following SARS-CoV-2 Infection.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2021
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

6 authors.

Cameron Mura *School of Data Science and Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA. cmura@virginia.edu.ORCID 0000-0001-7985-2561
Saskia Preissner *Department Oral and Maxillofacial Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany. Saskia.Preissner@charite.de.
Susanne NahlesDepartment Oral and Maxillofacial Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Max HeilandDepartment Oral and Maxillofacial Surgery, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.
Philip E BourneSchool of Data Science and Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA.
Robert PreissnerInstitute of Physiology and Science-IT, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Funding

National Science Foundation (NSF) MCB-1350957
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AspirinCOVID-19Histamine AntagonistsHistamine H2 AntagonistsHumansSARS-CoV-2AspirinHistamine AntagonistsHistamine H2 Antagonists

Identifiers

PMID34262013
PMCPMC8278809

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.